Heat Biologics' IPO

Heat Biologics raised a round of funding on July 24, 2013. Investors include Public.

Heat Biologics is a clinical-stage company focused on developing its off-the-shelf ImPACT therapeutic vaccines to combat a wide range of cancers and infectious diseases. ImPACT Therapy exploits the na…

Articles about Heat Biologics' IPO: